Liraglutide
Liraglutide is a synthetic GLP-1 receptor agonist used in research for type 2 diabetes and obesity. It is widely applied in both in vitro binding assays and in vivo metabolic studies to investigate mechanisms of glucose homeostasis and weight regulation.
Product Specifications
Product Name Alternative
NN2211, NN-2211, NN 2211, inhibit, Liraglutida, Liraglutide, Liraglutidum, Inhibitor, GCGR, GlucagonReceptor, Glucagon Receptor, GLP-1, Victoza
Field of Research
Pharmacology & Drug Discovery
Purity
97.65% (May vary between batches)
Solubility
H2O:5 mg/mL (1.33 mM)
Molecular Weight
3751.25
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62064R-BF680-01 20 µL
PSMD14 Recombinant Antibody, AbBy Fluor™ 680 Conjugated
Sign In for Pricing
View Details bsm-62064R-BF680-02 100 µL
PSMD14 Recombinant Antibody, AbBy Fluor™ 680 Conjugated
Sign In for Pricing
View Details 
abx525866 96 Tests
Human Probable G-protein coupled receptor 176 (GPR176) ELISA Kit
Sign In for Pricing
View Details 
LC410696 20 µg
C15orf44 (VWA9) (NM_030800) Human Over-expression Lysate
Sign In for Pricing
View Details